There is no known cure for Alzheimer's disease. But new hope (for mice at least) comes from an in-depth investigation of a class of drugs used to treat inflammatory diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
McGeer, P. L., Schulzer, M. & McGeer, E. G. Neurology 47, 425–432 (1996).
Breitner, J. C. Annu. Rev. Med. 47, 401–411 (1996).
Weggen, S. et al. Nature 414, 212–216 (2001).
Dominguez, D. I., De Strooper, B. & Annaert, W. Amyloid 8, 124–142 (2001).
Selkoe, D. J. Nature 399, A23–A31 (1999).
De Strooper, B. et al. Nature 398, 518–522 (1999).
Scheuner, D. et al. Nature Med. 2, 864–870 (1996).
Li, Y. M. et al. Nature 405, 689–694 (2000).
Lim, G. P. et al. J. Neurosci. 20, 5709–5714 (2000).
Jones, R. W. Lancet 358, 436–437 (2001).
Van Gool, W. A. et al. Lancet 358, 455–460 (2001).
Aisen, P. S. et al. Neurology 54, 588–593 (2000).
Schenk, D. et al. Nature 400, 173–177 (1999).
Fassbender, K. et al. Proc. Natl Acad. Sci. USA 98, 5856–5861 (2001).
Cherny, R. A. et al. Neuron 30, 665–676 (2001).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
De Strooper, B., König, G. An inflammatory drug prospect. Nature 414, 159–160 (2001). https://doi.org/10.1038/35102656
Issue Date:
DOI: https://doi.org/10.1038/35102656
